Pharmaceutical Industry Reports Telmisartan Market Size, Share, Outlook, and Analy Click to read
  • Comments

Pharmaceutical Industry Reports

Telmisartan Market Size, Share, Outlook, and Analy

Published on in “Health & Fitness”, language — English. 8 pages.
Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis. More
Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research. More

Other publications of “Pharmaceutical Industry Reports”

View all publications